Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer

BACKGROUND: The efficacy of combined modality therapy is evaluated for patients with extensive-stage (ES) small cell lung cancer (SCLC). This study evaluated prognostic factors affecting the risk of thoracic progression in ES-SCLC patients likely to undergo thoracic radiotherapy combined chemotherap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Fukui, Tomoya, Itabashi, Michiko, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kasajima, Masashi, Igawa, Satoshi, Sasaki, Jiichiro, Masuda, Noriyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782389/
https://ncbi.nlm.nih.gov/pubmed/26955807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2222-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky